Article
The MDM2 309T>G polymorphism and ovarian cancer risk: a meta-analysis of 1534 cases and 2211 controls.
PloS one - 1 Jan 2013
Ma Ying-Yu, Guan Tian-Pei, Yao Hai-Bo, Yu Sheng, Chen Le-Gao, Xia Ying-Jie, He Xu-Jun, Wang Hui-Ju, Jiang Xiao-Ting, Tao Hou-Quan
Abstract excerpt
BACKGROUND: Recently, there have been a number of studies on the association between MDM2 (Murine Double Minute 2) 309 polymorphism and ovarian cancer risk. However, the results of previous reports remain controversial and ambiguous. Thus, we performed a meta-analysis to explore more precisely the association between MDM2 309 polymorphism and the risk of ovarian cancer. METHODS: A meta-analysis was performed to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
